Company / Operating Cash Flow per Share
MANGOCEUTICALS, INC. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.18
FY2025
5-year range
-$4.90 / -$0.10
FY2023-FY2025
Trend
+96.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.10 to $-0.18 over the past 2 years.
Based on SEC 10-K filings.
-0.18 in FY2025.
Declined from $-0.10 to $-0.18 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 96.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.18 | +96.3% |
| FY2024 | -$4.90 | -4763.8% |
| FY2023 | -$0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026